TrademarkDir
CYTOTIL
LIVE

Serial Number

97928862

Owner

Obsidian Therapeutics, Inc.

Attorney

Olivia Maria Baratta

Filing Date

May 10, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CYTOTIL Trademark

Serial Number: 97928862 • Registration: 8034801

CYTOTIL is a trademark filed by Obsidian Therapeutics, Inc. on May 10, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Obsidian Therapeutics, Inc. (24 trademarks)

1030 Massachusetts Avenue, Fourth Floor
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

May 10, 2023

Registration Date

November 18, 2025

Goods & Services

medical and scientific research and development services in the fields of cell therapy, gene therapy, oncology, and immunotherapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Nov 18, 2025 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Oct 16, 2025 CNTA
EXAMINER'S AMENDMENT ENTERED
Sep 26, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 26, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 26, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 26, 2025 CNEA
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jul 9, 2025 GNS1
SUBSEQUENT FINAL EMAILED
Jul 9, 2025 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Jul 9, 2025 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 19, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 19, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 21, 2024 CNRT
USE AMENDMENT ACCEPTED
Nov 21, 2024 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Oct 17, 2024 AUPC
USE AMENDMENT FILED
Oct 17, 2024 IUAF
TEAS AMENDMENT OF USE RECEIVED
Oct 17, 2024 EAAU
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 17, 2024 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 23, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 23, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 17, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 17, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 17, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 14, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 14, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 18, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 18, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 18, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 14, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2023 NWOS
NEW APPLICATION ENTERED
May 13, 2023 NWAP

Related Trademarks

More from this Owner

CYTOTIL15

CYTOTIL15

CYTOTIL15

CYTOTIL15

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS

OBSIDIAN

OBSIDIAN

OBSIDIAN

OBSIDIAN